Expertise in
8
conditions

Yasushi O. Goto

Chuo, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Chuo, JP 

Overview

Yasushi Goto practices in Chuo, Japan. Goto is highly rated in 8 conditions, according to our data. Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, Tissue Biopsy, and Endoscopy.

Their clinical research consists of co-authoring 253 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Chuo, Japan
Other Locations
Tokyo, Japan
Toyoake, Japan
Kashiwa, Japan
Minato, 1050003, Japan
Hoshigaoka, Japan
Kobe, Japan
Hamamatsu, 4300929, Japan
Chuo, Japan
Tsukuba, 3058575, Japan
Hongo, Japan
Suita, Japan
Yaizu, 4210212, Japan
Nagoya, 4648602, Japan
Career Path Promotion Unit For Young Life Scientists, Yoshida Konoe Cho, Kyoto, Japan
Shinjuku, 1628655, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2

253 Total Publications

Strategic Combination Approaches in Cancer Immunotherapy
Strategic Combination Approaches in Cancer Immunotherapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 26, 2026

Frequently Asked Questions about Yasushi O. Goto

Is Yasushi O. Goto a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Yasushi O. Goto is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yasushi O. Goto participate in research or clinical trials?

Yes. Yasushi O. Goto has published 253 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Yasushi O. Goto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Goto's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile